4/2
07:08 am
vigl
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition [Yahoo! Finance]
Medium
Report
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition [Yahoo! Finance]
4/2
07:00 am
vigl
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
Medium
Report
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
3/14
10:12 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at Wedbush from $24.00 to $13.00. They now have an "outperform" rating on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at Wedbush from $24.00 to $13.00. They now have an "outperform" rating on the stock.
3/14
08:36 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at HC Wainwright from $17.00 to $14.00. They now have a "buy" rating on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at HC Wainwright from $17.00 to $14.00. They now have a "buy" rating on the stock.
3/13
07:00 am
vigl
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
Medium
Report
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
3/11
08:25 am
vigl
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum [Yahoo! Finance]
Low
Report
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum [Yahoo! Finance]
3/11
07:00 am
vigl
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
Low
Report
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
2/20
11:17 am
vigl
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
Low
Report
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
1/30
07:00 am
vigl
Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference
Medium
Report
Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference
1/24
11:30 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at Guggenheim.
High
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at Guggenheim.
1/23
12:50 pm
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
1/23
07:00 am
vigl
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
High
Report
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
1/8
04:05 pm
vigl
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
Low
Report
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones